Screening for Smoking in a General Hospital: Scale Validation, Indicators of Prevalence, and Comorbidity

Authors

  • Flávia de Lima Osório PhD,

    Corresponding author
    1. Flávia de Lima Osório, PhD, is a Psychologist, Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil and is a member of INCT Translational Medicine, Brazil; Ana Carolina Franco de Carvalho, is a Psychologist and a researcher at Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil; José Alexandre de Souza Crippa, MD, PhD, is Professor, Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil and is a member of INCT Translational Medicine, Brazil; and Sonia Regina Loureiro, PhD, is Professor, Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil and is a member of INCT Translational Medicine, Brazil.
    Search for more papers by this author
  • Ana Carolina Franco de Carvalho,

    1. Flávia de Lima Osório, PhD, is a Psychologist, Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil and is a member of INCT Translational Medicine, Brazil; Ana Carolina Franco de Carvalho, is a Psychologist and a researcher at Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil; José Alexandre de Souza Crippa, MD, PhD, is Professor, Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil and is a member of INCT Translational Medicine, Brazil; and Sonia Regina Loureiro, PhD, is Professor, Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil and is a member of INCT Translational Medicine, Brazil.
    Search for more papers by this author
  • José Alexandre de Souza Crippa MD, PhD,

    1. Flávia de Lima Osório, PhD, is a Psychologist, Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil and is a member of INCT Translational Medicine, Brazil; Ana Carolina Franco de Carvalho, is a Psychologist and a researcher at Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil; José Alexandre de Souza Crippa, MD, PhD, is Professor, Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil and is a member of INCT Translational Medicine, Brazil; and Sonia Regina Loureiro, PhD, is Professor, Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil and is a member of INCT Translational Medicine, Brazil.
    Search for more papers by this author
  • Sonia Regina Loureiro PhD

    1. Flávia de Lima Osório, PhD, is a Psychologist, Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil and is a member of INCT Translational Medicine, Brazil; Ana Carolina Franco de Carvalho, is a Psychologist and a researcher at Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil; José Alexandre de Souza Crippa, MD, PhD, is Professor, Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil and is a member of INCT Translational Medicine, Brazil; and Sonia Regina Loureiro, PhD, is Professor, Department of Neurosciences and Behavior, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto/São Paulo, Brazil and is a member of INCT Translational Medicine, Brazil.
    Search for more papers by this author

  • Conflict of Interest Statement: The authors report no actual or potential conflicts of interest.

  • Research supported by Reitoria de Pesquisa da Universidade de São Paulo (Process USP n°. 09.1.01689.17.7) and by Banco Santander (Process USP n°. 10.1.01232.17.9).

Author contact: flaliosorio@ig.com.br, with a copy to the Editor: gpearson@uchc.edu

Abstract

PURPOSE:  The study aims to conduct a psychometric study of the Fagerström Test for Nicotine Dependence (FTND) and to assess the prevalence, sociodemographic profile, and psychiatric comorbidities of smokers in a general hospital.

DESIGN AND METHODS:  Two hundred sixty-four inpatients were elegible for inclusion in the study and assessed with Structured Clinical Interview for the DSM-IV (Module E), Patient Health Questionnaire, Fast Alcohol Screening Test, and FTND.

FINDINGS:  The cut-off note two of the FTND is the most adequate to identify tobacco abuse/dependence (sensibility: 0.59–0.76). The reliability was estimated to be 0.68–0.96. A 44% rate of tobacco abuser/dependent patients was detected, with a 28% rate of psychiatric comorbidity.

PRACTICE IMPLICATIONS:  Detection of the smoking habits at the time of hospitalization can be opportune, favoring the planning and the beginning of treatment.

Ancillary